These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24222902)

  • 61. Review article: albumin for circulatory support in patients with cirrhosis.
    Ginès P; Guevara M; De Las Heras D; Arroyo V
    Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():24-31. PubMed ID: 12423450
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MELD score and albumin replacement are related to higher costs during management of patients with refractory ascites.
    Borges de Santana V; Bertocco de Paiva Haddad L; Morgado Conte T; Cortez Rizzon A; Miranda Barbosa V; Shield W; Andraus W; Augusto Carneiro D'Albuquerque L
    Transplant Proc; 2014; 46(6):1760-3. PubMed ID: 25131030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials.
    Salerno F; Navickis RJ; Wilkes MM
    Clin Gastroenterol Hepatol; 2013 Feb; 11(2):123-30.e1. PubMed ID: 23178229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.
    Bai M; Qi XS; Yang ZP; Yang M; Fan DM; Han GH
    World J Gastroenterol; 2014 Mar; 20(10):2704-14. PubMed ID: 24627607
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Midodrine versus Albumin to Prevent Paracentesis Induced Circulatory Dysfunction in Acute on Chronic Liver Failure Patients in the Outpatient Clinic-a Randomized Controlled Trial.
    Sujith Reddy JSN; Jagtap N; Kalpala R; Kulkarni A; Gupta R; Nagaraja Rao P; Iyengar S; Alla M; Nageshwar Reddy D; Sharma M
    J Clin Exp Hepatol; 2023; 13(4):576-585. PubMed ID: 37440947
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial.
    Thévenot T; Bureau C; Oberti F; Anty R; Louvet A; Plessier A; Rudler M; Heurgué-Berlot A; Rosa I; Talbodec N; Dao T; Ozenne V; Carbonell N; Causse X; Goria O; Minello A; De Ledinghen V; Amathieu R; Barraud H; Nguyen-Khac E; Becker C; Paupard T; Botta-Fridlung D; Abdelli N; Guillemot F; Monnet E; Di Martino V
    J Hepatol; 2015 Apr; 62(4):822-30. PubMed ID: 25463545
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Midodrine in Liver Cirrhosis With Ascites: A Systematic Review and Meta-Analysis.
    Shrestha DB; Budhathoki P; Sedhai YR; Baniya RK; Karki P; Jha P; Mainali G; Acharya R; Sodhi A; Kadaria D
    Cureus; 2022 Jul; 14(7):e27483. PubMed ID: 36060403
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial.
    Pereira RA; Virella D; Perdigoto R; Marcelino P; Saliba F; Germano N
    Trials; 2023 Aug; 24(1):534. PubMed ID: 37582719
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence and risk factors for unsuspected spontaneous ascitic fluid infection in cirrhotics undergoing therapeutic paracentesis in an outpatient clinic.
    Mohan P; Venkataraman J
    Indian J Gastroenterol; 2011 Sep; 30(5):221-4. PubMed ID: 21956818
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review.
    Kulkarni AV; Kumar P; Sharma M; Sowmya TR; Talukdar R; Rao PN; Reddy DN
    J Clin Transl Hepatol; 2020 Mar; 8(1):42-48. PubMed ID: 32274344
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis.
    Teh KB; Loo JH; Tam YC; Wong YJ
    Dig Liver Dis; 2021 Jul; 53(7):817-823. PubMed ID: 34011479
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Albumin for end-stage liver disease.
    Lee JS
    Korean J Intern Med; 2012 Mar; 27(1):13-9. PubMed ID: 22403494
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of albumin in two Spanish university hospitals.
    Vargas E; de Miguel V; Portolés A; Avendaño C; Ambit MI; Torralba A; Moreno A
    Eur J Clin Pharmacol; 1997; 52(6):465-70. PubMed ID: 9342582
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Incidence of spontaneous bacterial peritonitis among asymptomatic cirrhosis patients undergoing outpatient paracentesis: a systematic review and meta-analysis.
    Alotaibi A; Almaghrabi M; Ahmed O; Rodrigues D; Iansavichene A; Puka K; Gandhi R; Sey M; Patel K; Brahmania M
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e851-e857. PubMed ID: 34432678
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparing the Effects of Hydroxyethyl Starch and Albumin in Cirrhotic Patients with Tense Ascites; a Randomized Clinical Trial.
    Abootalebi A; Khazaei S; Minakari M; Nasr-Isfahani M; Esmailian M; Heydari F
    Adv J Emerg Med; 2017; 1(1):e7. PubMed ID: 31172059
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effectiveness of intravenous albumin therapy to prevent spontaneous bacterial peritonitis, renal dysfunction and death in adults with cirrhosis: a protocol for a systematic review.
    Härmälä S; Parisinos C; Ryan J; O'Brien A
    BMJ Open; 2019 Jan; 9(1):e025664. PubMed ID: 30700489
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Renal and circulatory effects of large volume plasma expansion in patients with hepatorenal syndrome type 1.
    Umgelter A; Wagner KS; Reindl W; Luppa PB; Geisler F; Huber W; Schmid RM
    Ann Hepatol; 2012; 11(2):232-9. PubMed ID: 22345341
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
    Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.